Politics
Culture
Business
Society
Media
Governance
Photo
Magazine
Archives
big pharma
Health
/
Commentary
How US pressure is endangering India’s access to affordable medicines
Round Up
A Selection of Long Reads from 2016
Law
/
Commentary
Why experts and activists are up in arms over the grant of a patent for a blockbuster hepatitis C drug
Vidya Krishnan
Government
/
News
What Happened to the Indian Official that Rejected the US Drug Company Gilead's Patent Application in 2015
Mandakini Gahlot
,
Vidya Krishnan
